Rygen Biopharma Private Limited - Company Profile

It is a agriculture private limited company based in Seri Lingampally, Telangana, India, established in 2020.
2020 Seri Lingampally, Telangana, India Active
Last Updated:
Access Report
About Rygen Biopharma Private Limited

Rygen Biopharma Private Limited, a active private limited company, was established on 17 December 2020 in Seri Lingampally, Telangana, India. Engaging in agro retail & distribution within the manufacturing sector, it holds CIN: U24304TG2020PTC146965. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹7.50 Cr and a paid-up capital of ₹6.35 Cr.

Its leadership includes Tulasiramu Chatadi (Director), Venkata Krishna Rao Dasari (Director), Vatti Sleeva Reddy (Managing Director). Past directors included Tulasiramu Chatadi, Vatti Sleeva Reddy, Yelma Venkat Reddy. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H.No.1-26/3/A/4F/Nr,4Th Floor,S.S.Towers, Gachibowli Old Village, Seri Lingampally, Telangana, 500032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304TG2020PTC146965

  • Registration Number

    146965

  • Incorporation Date

    17 December 2020

  • Authorized Capital

    ₹7.50 Cr

  • Paid-Up Capital

    ₹6.35 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 7.50 Cr
  • Paid Up Capital ₹ 6.35 Cr
  • Company Age 5 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** -69.72%
  • Ebitda **** -67.00%
  • Net Worth -42.43%
  • Total Assets **** 1.27%
Company report

Rygen Biopharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rygen Biopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Rygen Biopharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Tulasiramu Chatadi Director 17 Jan 2024 Current
Venkata Krishna Rao Dasari Director 17 Dec 2020 Current
Vatti Sleeva Reddy Managing Director 06 Mar 2024 Current
Vineeth Reddy Vatti Additional Director 06 Nov 2024 Current
Praneeth Vatti Additional Director 06 Nov 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 22 Oct 2021 Past
Pramod Abcsdd Director 13 Oct 2024 Past
Pramod Abcsdd Director 22 Oct 2021 Past
Pramod Abcsdd Director 02 Apr 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rygen Biopharma.

Rygen Biopharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 69.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 42.43%.

Rygen Biopharma revenue growth over time
Rygen Biopharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 1.27%
*******
*******
*******
*******
Profit or Loss
*******
 -69.72%
*******
*******
*******
*******
Net Worth
*******
 -42.43%
*******
*******
*******
*******
EBITDA
*******
 -67.00%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rygen Biopharma?

Unlock access to Rygen Biopharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Rygen Biopharma?

Rygen Biopharma has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rygen Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rygen Biopharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rygen Biopharma
Recent Activity within the Organization
  • Annual General Meeting

    Rygen Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Rygen Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Director Appointment

    Vineeth Reddy Vatti was appointed as a Additional Director was appointed as a Additional Director on 06 Nov 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.

  • Director Appointment

    Progress on Praneeth Vatti was appointed as a Additional Director was appointed as a Additional Director on 06 Nov 2024 & has been associated with this company since 1 year 3 months . was documented.

  • Director Appointment

    Progress on Vatti Sleeva Reddy was appointed as a Managing Director was appointed as a Managing Director on 06 Mar 2024 & has been associated with this company since 1 year 11 months . was documented.

  • Director Appointment

    Tulasiramu Chatadi was appointed as a Director was appointed as a Director on 17 Jan 2024 & has been associated with this company since 2 years 1 month . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rygen Biopharma Private Limited?

The CIN of Rygen Biopharma Private Limited is U24304TG2020PTC146965.

Where is Rygen Biopharma Private Limited headquartered?

Rygen Biopharma Private Limited is headquartered at H.No.1-26/3/A/4F/Nr,4Th Floor,S.S.Towers, Gachibowli Old Village, Seri Lingampally, Telangana, 500032.

When was Rygen Biopharma Private Limited incorporated?

Rygen Biopharma Private Limited was incorporated on 17 December 2020.

Who are the current directors of Rygen Biopharma Private Limited?

The current directors of Rygen Biopharma Private Limited are

What is the primary industry of Rygen Biopharma Private Limited?

The primary industry of Rygen Biopharma Private Limited is Manufacturing.

Is Rygen Biopharma Private Limited a listed company?

Rygen Biopharma Private Limited is unlisted.

What is the capital structure of Rygen Biopharma Private Limited?

The authorized capital of Rygen Biopharma Private Limited is ₹7.50 Cr, and the paid-up capital is ₹6.35 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available